Merck sells biosimilars business to Fresenius
admin 25th April 2017 Uncategorised 0Merck has divested its biosimilars business to fellow German drugmaker Fresenius in a deal potentially worth 670 million euros.
More: Merck sells biosimilars business to Fresenius
Source: News